UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) July 22, 2010

 

 

Cellu Tissue Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-34606   06-1346495

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

1855 Lockeway Drive

Suite 501

Alpharetta, Georgia

  30004
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code (678) 393-2651

 

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 5.07 SUBMISSION OF MATTERS TO A VOTE OF THE SECURITY HOLDERS.

On July 22, 2010, Cellu Tissue Holdings, Inc. held its annual meeting of stockholders. Proxies for the meeting were solicited pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended. The following matters were submitted to a vote of the stockholders.

Votes regarding the election of two directors to serve until the annual meeting of the stockholders in 2013 or until their successors are duly elected and have qualified were as follows:

 

Name

   For    Withheld    Broker

David L. Ferguson

   17,521,378    701,361    1,600

Russell C. Taylor

   17,923,749    298,990    1,600

 

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

       

Cellu Tissue Holdings, Inc.

(Registrant)

Date: July 27, 2010

    By:  

/s/ W. Edwin Litton

     

Mr. W. Edwin Litton

Senior Vice President – General Counsel and Secretary

 

 

3

Canada Life (NYSE:CLU)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025 Plus de graphiques de la Bourse Canada Life
Canada Life (NYSE:CLU)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025 Plus de graphiques de la Bourse Canada Life